Comparison | Estimated correlation | Lower bound 95% CI | Upper bound 95% CI | p-valuea |
---|---|---|---|---|
Healthy sites in periodontally diseased and periodontally healthy control subjects (N = 31) | ||||
PD-L1 vs IL6 | − 0.35 | − 0.63 | 0.00 | 0.05 |
PD-L1 vs CXCL8 | − 0.56 | − 0.76 | − 0.26 | 0.001 |
PD-L1 vs IL10 | − 0.43 | − 0.68 | − 0.09 | 0.02 |
PD-L1 vs CCL3 | − 0.37 | − 0.64 | − 0.01 | 0.04 |
Diseased sites in periodontally diseased subjects (N = 20) | ||||
PD-L1 vs CCL11 | 0.51 | 0.09 | 0.78 | 0.02 |
PD-L1 vs CSF2 | 0.69 | 0.36 | 0.87 | 0.001 |
PD-L1 vs IFNG | 0.49 | 0.06 | 0.77 | 0.03 |
PD-L1 vs IL12A | − 0.54 | − 0.79 | − 0.13 | 0.01 |
PD-L1 vs IL1A | 0.46 | 0.03 | 0.75 | 0.04 |
PD-L1 vs IL1B | 0.56 | 0.15 | 0.80 | 0.01 |
PD-L1 vs IL2 | 0.50 | 0.07 | 0.77 | 0.03 |
PD-L1 vs IRX1 | − 0.55 | − 0.80 | − 0.15 | 0.01 |
PD-L1 vs IL7 | 0.61 | 0.23 | 0.83 | 0.004 |
PD-L1 vs IL15 | 0.64 | 0.27 | 0.84 | 0.003 |
PD-L1 vs CCL5 | 0.50 | 0.07 | 0.77 | 0.03 |